BRUNETTI, JLENIA
 Distribuzione geografica
Continente #
EU - Europa 4.812
NA - Nord America 4.545
AS - Asia 911
SA - Sud America 97
AF - Africa 13
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.393
Nazione #
US - Stati Uniti d'America 4.520
GB - Regno Unito 1.295
IT - Italia 1.141
IE - Irlanda 718
CN - Cina 423
SE - Svezia 357
RU - Federazione Russa 290
UA - Ucraina 270
SG - Singapore 246
DE - Germania 222
FR - Francia 181
FI - Finlandia 105
BR - Brasile 76
VN - Vietnam 73
ES - Italia 59
BE - Belgio 50
IN - India 29
NL - Olanda 21
PL - Polonia 21
IR - Iran 20
TR - Turchia 19
AT - Austria 18
CZ - Repubblica Ceca 18
CA - Canada 17
HK - Hong Kong 14
BD - Bangladesh 13
AU - Australia 9
IL - Israele 9
PK - Pakistan 9
PH - Filippine 8
AR - Argentina 7
CH - Svizzera 7
RO - Romania 7
CI - Costa d'Avorio 6
IQ - Iraq 6
DK - Danimarca 5
JP - Giappone 5
KZ - Kazakistan 5
MX - Messico 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
VE - Venezuela 4
AM - Armenia 3
AZ - Azerbaigian 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
KG - Kirghizistan 3
MA - Marocco 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SA - Arabia Saudita 3
BY - Bielorussia 2
CL - Cile 2
EC - Ecuador 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 10.393
Città #
Southend 1.208
Dublin 708
Fairfield 567
Chandler 402
Siena 394
Ashburn 351
Woodbridge 277
Ann Arbor 272
Santa Clara 271
Seattle 224
Houston 221
Jacksonville 221
Wilmington 202
Menlo Park 171
Cambridge 159
Singapore 113
Beijing 107
Princeton 104
New York 76
Florence 74
Dong Ket 70
Nanjing 69
Boardman 63
Helsinki 58
Rome 57
Milan 54
Málaga 48
San Diego 39
Fremont 37
Shanghai 37
Brussels 36
Council Bluffs 36
Dearborn 32
Nanchang 31
San Mateo 30
Hebei 26
Los Angeles 24
London 22
Shenyang 22
Washington 22
Bagno a Ripoli 21
Moscow 17
Brno 16
Redwood City 15
Tianjin 15
Vienna 15
Gdansk 14
Naples 14
Chicago 13
Kunming 12
Izmir 11
Lappeenranta 11
Phoenix 11
Dallas 10
Nuremberg 10
Toronto 9
Hong Kong 8
Jiaxing 8
Jinan 8
Ningbo 8
Portsmouth 8
Arezzo 7
Atlanta 7
Changsha 7
Colle Di Val D'elsa 7
Columbus 7
Düsseldorf 7
Ghent 7
Guangzhou 7
Munich 7
Norwalk 7
Zanjan 7
Abidjan 6
Barcelona 6
Dhaka 6
Falkenstein 6
Grosseto 6
Napoli 6
Piscataway 6
Salerno 6
Turin 6
Campagnano Di Roma 5
Delhi 5
Frankfurt am Main 5
Leawood 5
Lima 5
Manila 5
Overijse 5
Palermo 5
Radomsko 5
San Francisco 5
Tappahannock 5
University Park 5
Zhengzhou 5
Bologna 4
Brescia 4
Como 4
Fuzhou 4
Hangzhou 4
Kilburn 4
Totale 7.409
Nome #
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 275
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 274
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 270
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 267
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 244
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 240
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 236
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 236
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 223
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 223
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 215
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 212
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 211
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 210
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 209
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 207
A new NT4 peptide-based drug delivery system for cancer treatment 198
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 194
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 183
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 179
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 178
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 177
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 176
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 174
Branched peptides as bioactive molecules for drug design 173
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 173
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 170
null 165
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 164
Branched peptides as targeting agents for tumor imaging and therapy 154
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 153
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 153
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 153
Nanoparticles exposing neurotensin tumor-specific drivers 149
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 147
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 143
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 142
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 141
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 136
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 136
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 135
Branched Neurotensin peptides for tumor personalized therapy 132
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 130
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 129
The antimicrobial peptide M33. An example of drug development 128
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 123
Tumor selective targeting by branched peptides 122
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 122
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 120
The antimicrobial peptide M33. An example of drug development 119
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 115
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 114
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 113
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 112
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 111
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 106
null 105
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 104
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 103
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 100
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 80
null 78
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 69
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 69
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 57
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 56
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 55
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 54
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 42
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 37
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 37
Editorial: Proteoglycans in the Tumor Microenvironment 10
Totale 10.650
Categoria #
all - tutte 36.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020461 0 0 0 0 0 0 0 0 155 154 58 94
2020/20211.685 72 105 35 130 66 198 201 214 119 283 106 156
2021/20221.157 71 98 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/20251.552 77 100 309 125 305 145 116 183 192 0 0 0
Totale 10.650